Impact of diabetes duration on left ventricular mass regression with empagliflozin

AIMS: The duration of type 2 diabetes mellitus (T2DM) is an important determinant of diabetes severity. The EMPA‐HEART CardioLink‐6 trial reported significant left ventricular (LV) mass indexed to body surface area (LVMi) regression in patients treated with the sodium‐glucose cotransporter 2 inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Moroney, Michael, Verma, Raj, Hibino, Makoto, Mazer, C. David, Connelly, Kim A., Yan, Andrew T., Quan, Adrian, Teoh, Hwee, Verma, Subodh, Puar, Pankaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192246/
https://www.ncbi.nlm.nih.gov/pubmed/37038614
http://dx.doi.org/10.1002/ehf2.14357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192246/
https://www.ncbi.nlm.nih.gov/pubmed/37038614
http://dx.doi.org/10.1002/ehf2.14357

Ejemplares similares